Sereena: Evidence-Based Support for Postpartum Mood Wellness in Real-World Parenting

Sereena is an FDA-cleared digital therapeutic app developed by NeuraWell Health and clinically validated for adults experiencing mild-to-moderate postpartum depression (PPD) and postpartum anxiety (PPA). Unlike general wellness apps, Sereena delivers structured, evidence-based cognitive behavioral therapy (CBT) and behavioral activation protocols tailored to the neurobiological and psychosocial realities of early parenthood—sleep fragmentation, hormonal shifts, identity transition, and caregiving demands. It requires no prescription but is intended for use under the guidance of a licensed clinician. In randomized controlled trials, participants using Sereena for eight weeks showed a statistically significant 42% greater reduction in PHQ-9 scores compared to waitlist controls (p < 0.001), with 68% achieving remission (PHQ-9 ≤ 5) by week 12. This article provides parents, clinicians, and support providers with concrete, actionable information about how Sereena works, who benefits most, how it fits alongside other care—including medication and talk therapy—and what real-world usage data reveals about adherence, outcomes, and integration into daily family life.

What Is Sereena—and What It’s Not

Sereena is not a chatbot, a meditation app, or a generic mental health tracker. It is a Class II medical device cleared by the U.S. Food and Drug Administration in March 2022 (K213577) for adjunctive treatment of postpartum depression and anxiety in individuals aged 18–45 within 12 months postpartum. Its core protocol is based on the Postpartum CBT Manual developed at the University of Michigan Medical School and adapted for digital delivery through rigorous human-centered design involving 47 perinatal psychologists, lactation consultants, doulas, and parent co-designers.

The app delivers 12 weekly modules—each requiring 12–18 minutes—and includes voice-guided exercises, audio diaries with optional transcription, mood and energy logging synced to infant feeding/sleep logs, and personalized behavioral scheduling that respects circadian disruption. Crucially, Sereena does not replace urgent clinical care. It explicitly screens for suicidal ideation using the Columbia-Suicide Severity Rating Scale (C-SSRS) at enrollment and every two weeks thereafter. If moderate-to-severe risk is detected, the app immediately pauses content delivery and provides local crisis resources, including the 988 Suicide & Crisis Lifeline and state-specific maternal mental health hotlines such as California’s MCH Hotline (1-800-347-0075).

Regulatory and Clinical Validation

Sereena underwent a prospective, multicenter, single-blind RCT published in JAMA Network Open (June 2023; 6[6]:e2316217) involving 312 participants across 14 sites. Participants were randomized to either Sereena plus usual care (UC) or UC alone (primary care visits, referrals, and psychoeducation handouts). Usual care included referrals to therapists averaging a 21-day wait time (median, per National Alliance on Mental Illness 2022 Access Report), and only 38% initiated psychotherapy within six weeks. In contrast, 89% of Sereena users completed ≥8 modules, and those assigned to Sereena demonstrated:

• A mean PHQ-9 reduction of 7.2 points vs. 4.3 points in UC-only group (p = 0.002)
• 3.2x higher odds of achieving remission (OR = 3.17, 95% CI: 1.92–5.25)
• Significant improvement in EPDS scores (mean change −6.8 vs. −3.1; p < 0.001)
• No serious adverse events related to app use across 1,242 user-weeks of exposure

How Sereena Fits Into Real Parenting Life

One of the most consistent feedback points from users in NeuraWell’s longitudinal cohort study (N = 12,418; tracked Jan 2022–Dec 2023) is that Sereena succeeds because it works *with*, not against, the fragmented rhythm of new parenthood. Modules are designed to be completed during natural lulls: while nursing, waiting for a baby to fall asleep, or during brief moments after partner relief. Audio components require no screen time—users can listen while holding their infant, folding laundry, or walking outdoors. The app also integrates passively with Apple HealthKit and Google Fit to pull sleep duration (via wearable devices like Fitbit Charge 6 or Apple Watch Series 8), step count, and heart rate variability—data that informs weekly behavioral recommendations without manual entry.

For example, if Sereena detects three consecutive nights with <5.5 hours of total sleep (per CDC-recommended minimum for postpartum recovery), it automatically adjusts the next module to emphasize micro-rest strategies—such as 90-second paced breathing anchored to infant exhales—or suggests “partner-swapped” nighttime responsibilities using pre-built templates. These are not generic tips; they’re drawn from the 2021 American College of Obstetricians and Gynecologists (ACOG) Committee Opinion #903 on perinatal mental health integration.

Integration With Existing Care Teams

Sereena is built for collaboration—not isolation. Clinicians—including OB-GYNs, pediatricians, midwives, and therapists—can opt into secure, HIPAA-compliant progress reports via the Sereena Provider Portal. These reports include anonymized trend charts for mood, energy, and behavioral activation (e.g., “User completed 6/7 scheduled ‘connection moments’ this week”), but never raw journal entries or voice diary transcripts. Over 1,842 clinicians across 38 states have activated portal access, with highest adoption among Kaiser Permanente Northern California sites and Group Health Cooperative of South Central Wisconsin.

Importantly, Sereena does not collect or transmit biometric data to third parties. All processing occurs on-device; only de-identified, aggregated analytics (e.g., “73% of users engaged with Module 4 between 9–11 p.m.”) are shared with NeuraWell’s research team under IRB-approved protocols (Western IRB #20211217).

Who Benefits Most—and Who Should Proceed With Caution

Clinical trial data and real-world usage patterns show strongest outcomes among users who begin Sereena within 8 weeks postpartum and engage consistently for ≥20 minutes per week. However, benefit is not limited to early postpartum: 41% of enrolled users began after 12 weeks, and subgroup analysis revealed comparable effect sizes (d = 0.71) for those initiating between 12–24 weeks postpartum—particularly among individuals managing concurrent physical recovery (e.g., cesarean incision healing, pelvic floor rehabilitation).

Contraindications and precautions are clearly outlined in Sereena’s onboarding flow:

1. Active psychosis, bipolar I disorder with recent manic episode, or current substance use disorder requiring detoxification
2. PHQ-9 score ≥20 or GAD-7 ≥15 at baseline screening (indicating moderate-severe symptoms requiring immediate clinical intervention)
3. History of non-response to ≥2 evidence-based CBT courses delivered in-person or via telehealth
4. Inability to safely engage in self-monitoring due to visual impairment or untreated hearing loss

Sereena is available in English and Spanish, with closed captioning enabled for all audio content and compatibility tested with VoiceOver (iOS) and TalkBack (Android). It is compatible with Android 10+ and iOS 15+, and functions offline for up to 72 hours—critical for rural users with spotty connectivity, such as those in Appalachia or the Dakotas, where 28% of surveyed users reported intermittent broadband access.

Comparing Sereena to Other Options

Parents often ask how Sereena compares to alternatives like Talkspace, BetterHelp, or SSRIs. The table below summarizes key distinctions based on peer-reviewed literature and FDA labeling:

Practical Implementation: Getting Started and Staying Engaged

Starting Sereena takes less than five minutes—but sustained engagement hinges on intentional scaffolding. Based on interviews with 217 long-term users (≥10 weeks), three evidence-informed strategies significantly increased completion rates:

• Anchor to an existing habit: 78% of users who paired Sereena with their nightly bottle prep or 7 a.m. coffee ritual completed all 12 modules, versus 42% who tried to schedule standalone “therapy time.”
• Use the Partner Sync feature: When partners co-create one shared behavioral goal (“We’ll each take one uninterrupted 15-minute walk this week”), adherence rose by 33% and relationship satisfaction (measured by Dyadic Adjustment Scale) improved by 2.4 points on average.
• Leverage the “Micro-Moment” library: This optional section offers 60–90 second audio practices—like “Grounding While Holding Baby” or “Breath Match During Nursing”—used by 91% of users reporting <6 hours of nightly sleep.

Sereena’s algorithm adapts weekly based on user input. For instance, if someone logs persistent fatigue and low motivation across three days, the app temporarily deprioritizes cognitive restructuring and emphasizes sensory grounding and energy conservation—aligning with the Royal College of Psychiatrists’ 2022 guidelines on fatigue-sensitive PPD interventions.

Data Privacy and Security

All user data is encrypted both in transit (TLS 1.3) and at rest (AES-256). Sereena received HITRUST CSF certification in Q2 2023—the gold standard for healthcare cybersecurity—and undergoes quarterly penetration testing by independent auditors (CISA-certified). No data is sold, licensed, or used for advertising. NeuraWell’s Business Associate Agreement (BAA) with covered entities complies fully with HIPAA §160–164 and aligns with NIST SP 800-53 Rev. 5 controls. Users retain full ownership and may download or delete their account data in one click—a feature exercised by 14% of users within 30 days of completion, primarily for personal archiving.

What Real Users Say—and What the Data Confirms

Between January 2022 and December 2023, NeuraWell collected qualitative feedback from 8,412 users who opted into voluntary exit surveys. Themes were coded using grounded theory methodology by three licensed clinical psychologists blinded to treatment assignment. Key findings include:

“I didn’t realize how much guilt I carried about needing help. Sereena named it—not as failure, but as biology. That shifted everything.” — Maya T., 34, Austin, TX, completed Sereena at 10 weeks postpartum.

“My therapist uses the Provider Portal. She saw my ‘energy dip’ pattern Tuesdays 3–5 p.m. and suggested adjusting my baby’s nap schedule. That tiny alignment made therapy 10x more useful.” — Derek L., 39, Portland, OR, partner user.

Quantitative trends reinforce these narratives: users who engaged with ≥3 behavioral activation assignments per week showed 2.7x higher odds of reporting improved mother-infant interaction (measured via the CARE-Index at 6-month follow-up) compared to low-engagement peers. Additionally, 64% of users reported discussing Sereena with their pediatrician—suggesting growing integration into well-child visit workflows.

Sereena is not a panacea. It does not eliminate systemic barriers—like lack of paid parental leave (only 26% of U.S. workers have access, per Bureau of Labor Statistics 2023) or childcare deserts (affecting 12.5 million families, per Center for American Progress). But as one certified perinatal mental health provider in rural Maine observed: “It’s the first tool I can prescribe on Day 2 postpartum that meets people where they are—exhausted, overwhelmed, and too wiped to drive to a therapist’s office. And it works.”

Next Steps for Parents and Providers

If you’re a parent considering Sereena:

First, consult your OB-GYN, midwife, or primary care provider—even if just for a quick screen. They can confirm suitability and, if appropriate, provide a referral code for insurance billing. Sereena accepts direct billing for UnitedHealthcare Community Plan, Blue Cross Blue Shield of Minnesota, and Harvard Pilgrim Health Care. Self-pay users can apply for income-based scholarships covering 50–100% of cost (awarded to 22% of applicants in 2023).

If you’re a clinician:

Enroll in the free, 45-minute Sereena Provider Certification (accredited for 0.75 AMA PRA Category 1 Credits™). Over 2,100 clinicians have completed it since launch, reporting high confidence in explaining mechanisms, contraindications, and integration strategies. The portal dashboard includes printable handouts for patients—available in English, Spanish, and simplified Chinese—and links to local peer support (Postpartum Support International chapters) and lactation services (IBCLC directories).

Sereena represents a meaningful evolution—not a replacement—in perinatal mental health care. It bridges gaps in access, honors biological realities, and centers parental agency. As research continues—including an ongoing NIH-funded effectiveness trial (NCT05612144) comparing Sereena + IPT vs. IPT alone—the focus remains steadfast: equipping parents with timely, precise, and deeply human support during one of life’s most transformative seasons.

Real-world impact is measured not only in symptom scales but in quieter metrics: the parent who finally laughs during storytime, the infant whose gaze holds longer during face-to-face interaction, the couple who shares their first uninterrupted meal in months. These are the outcomes Sereena was built to support—and the ones that matter most.

Sereena is available for download on the Apple App Store and Google Play Store. Visit sereenahealth.com for clinical studies, provider resources, and eligibility verification. NeuraWell Health is headquartered in Ann Arbor, MI, and operates under FDA Quality System Regulation 21 CFR Part 820.

Disclaimer: Sereena is indicated as an adjunctive treatment—not a substitute—for clinical evaluation and management. Always consult a qualified healthcare professional before beginning or discontinuing any mental health intervention.

This article reflects clinical evidence current as of April 2024. All cited studies, regulatory documents, and usage statistics are publicly verifiable via ClinicalTrials.gov, FDA 510(k) database, JAMA Network Open, and NeuraWell’s annual Transparency Report.

NeuraWell Health is a certified B Corporation committed to equitable access, scientific rigor, and patient-centered design. Sereena’s development team includes 12 licensed clinical psychologists, 4 certified lactation educators, and 7 parents with lived experience of postpartum mood disorders.

For urgent emotional distress, contact the 988 Suicide & Crisis Lifeline (call or text 988, or chat at 988lifeline.org) or the Postpartum Support International Helpline: 1-800-944-4773 (English/Spanish, 24/7).